South Korea Signs Agreement for Israeli Vaccines that Palestinians Rejected
The Israel-South Korea
vaccine agreement disproves the Palestinians’ claim that it rejected 1 million
doses of coronavirus vaccines because they were too close to their expiration
date.
Israel and South Korea
signed a mutual vaccine supply agreement on Tuesday which will “facilitate the
effective utilization of the present and future vaccine inventories of both
countries.”
According to the
agreement, Israel will immediately transfer approximately 700,000 doses of the
Pfizer vaccine to South Korea for the vaccination of its citizens by the end of
July.
In June, the Palestinian
Authority rejected 1 million doses of coronavirus vaccines from Israel only
hours after a deal was announced, claiming the doses were too close to their
expiration date.
Israel disproved that
claim, both by administering the doses to its citizens and by signing the
agreement with South Korea.
In the exchange
announced on Tuesday, South Korea will return the same quantity of vaccines to
Israel from a future order in September-October 2021.
This is the first
agreement of its kind for the exchange of coronavirus vaccines that has been
signed between Israel and another country.
“The State of Israel
welcomes the agreement and sees mutual advantages in it for both Israel and
South Korea,” the Prime Minister’s Office stated.
Prime Minister Naftali
Bennett has spoken with Pfizer CEO Albert Bourla recently to facilitate the
deal.
Bennett said that “we
have made a win-win deal: South Korea will receive vaccines from our existing
stocks and we will receive vaccines from their future shipment.”
No comments:
Post a Comment